missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Risedronate, R&D Systems™
Description
Orally active biphosphonate that inhibits farnesyl diphosphate (FPP) synthase (IC50 = 100 nM). Exhibits antiproliferative and proapoptotic activity in numerous tumor cell lines and inhibits osteoclast-mediated bone resorption in vivo.
Specifications
Specifications
| CAS | 115436-72-1 |
| Molecular Formula | C7H10NNaO7P2 |
| MDL Number | MFCD00867080,MFCD01706268,MFCD00867080 |
| Quantity | 50 mg |
| Synonym | risedronate sodium |
| InChI Key | DRFDPXKCEWYIAW-UHFFFAOYNA-M |
| SMILES | [Na+].OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)([O-])=O |
| IUPAC Name | sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate |
| Molecular Weight (g/mol) | 305.09 |
| PubChem CID | 131675130 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?